Why is it so important not to shake the vial
GLP-1 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 - Landscape Led by China and the U.S., Rising Partnerships, and Strong DTC-Driven Demand Push Biologics Above 65% Share The GLP-1 market is primed for substantial growth due to rising obesity and diabetes rates
These include GLP1/glucagon dual agonists (AstraZeneca, Boehringer Ingelheim, Hanmi Pharma, Eli Lilly) , GIP/GLP1/glucagon tri-agonists (Hanmi Pharmaceuticals, Eli Lilly), or solo GIPR agonists (Eli Lilly, Zealand Pharma)
Macrophage membrane [MCMs] group
In a separate cohort of chow-maintained rats, the effects of acute administration of an amylin/calcitonin receptor agonist and GLP-1R agonist were examined
Furthermore, human glioblastoma cells do not rely much on circulating glutamine for proliferation but rather more on glutamate to synthesize glutamine via glutamine synthetase to fuel purine biosynthesis 193